287114-27-6 Usage
General Description
1-(5-NITRO-2-PYRIDYL)-1,4-DIAZEPANE is a chemical compound with the molecular formula C10H13N3O2. It is a diazepane derivative with a nitro-substituted pyridine ring. 1-(5-NITRO-2-PYRIDYL)-1,4-DIAZEPANE has potential applications in the field of organic synthesis and medicinal chemistry, as it possesses interesting biological activities such as antimicrobial and anticancer properties. Its unique chemical structure makes it a valuable building block for the synthesis of new pharmaceutical compounds and other functional molecules. As a result, 1-(5-NITRO-2-PYRIDYL)-1,4-DIAZEPANE is a subject of interest for researchers and scientists working in various areas of chemistry and pharmacology.
Check Digit Verification of cas no
The CAS Registry Mumber 287114-27-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,7,1,1 and 4 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 287114-27:
(8*2)+(7*8)+(6*7)+(5*1)+(4*1)+(3*4)+(2*2)+(1*7)=146
146 % 10 = 6
So 287114-27-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H14N4O2/c15-14(16)9-2-3-10(12-8-9)13-6-1-4-11-5-7-13/h2-3,8,11H,1,4-7H2
287114-27-6Relevant articles and documents
MEDICINAL COMPOSITION
-
, (2008/06/13)
The present invention is composed of a pharmaceutical composition for the therapy of nephritis which comprises an amide derivative represented by the following formula [1] or pharmaceutically acceptable salt thereof, as an active ingredient: ???wherein R1 and R2 may be the same or different and each is hydrogen, alkyl which may be substituted, acyl, aryl which may be substituted, or an aromatic heterocyclic group which may be substituted; R3, R4, R5 and R6 may be the same or different and each is hydrogen, halogen, hydroxy, amino which may be substituted, alkyl which may be substituted, alkoxy or nitro and the like; and R7 represents cyclic amino which may be substituted or azabicycloalkylamino which may be substituted. The pharmaceutical composition of the invention is useful for the therapy of nephritis.
